Front Immunol. 2021 Aug 12;12:708186. doi: 10.3389/fimmu.2021.708186. eCollection 2021.
Macrophages: The Good, the Bad, and the Gluttony.
Frontiers in immunology
Ewan A Ross, Andrew Devitt, Jill R Johnson
Affiliations
Affiliations
- School of Biosciences, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom.
PMID: 34456917
PMCID: PMC8397413 DOI: 10.3389/fimmu.2021.708186
Abstract
Macrophages are dynamic cells that play critical roles in the induction and resolution of sterile inflammation. In this review, we will compile and interpret recent findings on the plasticity of macrophages and how these cells contribute to the development of non-infectious inflammatory diseases, with a particular focus on allergic and autoimmune disorders. The critical roles of macrophages in the resolution of inflammation will then be examined, emphasizing the ability of macrophages to clear apoptotic immune cells. Rheumatoid arthritis (RA) is a chronic autoimmune-driven spectrum of diseases where persistent inflammation results in synovial hyperplasia and excessive immune cell accumulation, leading to remodeling and reduced function in affected joints. Macrophages are central to the pathophysiology of RA, driving episodic cycles of chronic inflammation and tissue destruction. RA patients have increased numbers of active M1 polarized pro-inflammatory macrophages and few or inactive M2 type cells. This imbalance in macrophage homeostasis is a main contributor to pro-inflammatory mediators in RA, resulting in continual activation of immune and stromal populations and accelerated tissue remodeling. Modulation of macrophage phenotype and function remains a key therapeutic goal for the treatment of this disease. Intriguingly, therapeutic intervention with glucocorticoids or other DMARDs promotes the re-polarization of M1 macrophages to an anti-inflammatory M2 phenotype; this reprogramming is dependent on metabolic changes to promote phenotypic switching. Allergic asthma is associated with Th2-polarised airway inflammation, structural remodeling of the large airways, and airway hyperresponsiveness. Macrophage polarization has a profound impact on asthma pathogenesis, as the response to allergen exposure is regulated by an intricate interplay between local immune factors including cytokines, chemokines and danger signals from neighboring cells. In the Th2-polarized environment characteristic of allergic asthma, high levels of IL-4 produced by locally infiltrating innate lymphoid cells and helper T cells promote the acquisition of an alternatively activated M2a phenotype in macrophages, with myriad effects on the local immune response and airway structure. Targeting regulators of macrophage plasticity is currently being pursued in the treatment of allergic asthma and other allergic diseases. Macrophages promote the re-balancing of pro-inflammatory responses towards pro-resolution responses and are thus central to the success of an inflammatory response. It has long been established that apoptosis supports monocyte and macrophage recruitment to sites of inflammation, facilitating subsequent corpse clearance. This drives resolution responses and mediates a phenotypic switch in the polarity of macrophages. However, the role of apoptotic cell-derived extracellular vesicles (ACdEV) in the recruitment and control of macrophage phenotype has received remarkably little attention. ACdEV are powerful mediators of intercellular communication, carrying a wealth of lipid and protein mediators that may modulate macrophage phenotype, including a cargo of active immune-modulating enzymes. The impact of such interactions may result in repair or disease in different contexts. In this review, we will discuss the origin, characterization, and activity of macrophages in sterile inflammatory diseases and the underlying mechanisms of macrophage polarization
Copyright © 2021 Ross, Devitt and Johnson.
Keywords: apoptosis; arthritis (including rheumatoid arthritis); asthma; inflammation; macrophage
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
- Arthritis Rheum. 2009 Apr;60(4):966-75 - PubMed
- Blood. 2008 Dec 15;112(13):5026-36 - PubMed
- Nat Rev Rheumatol. 2016 Aug;12(8):472-85 - PubMed
- Mol Biol Rep. 2020 May;47(5):3423-3437 - PubMed
- Immunity. 2016 Mar 15;44(3):439-449 - PubMed
- Nature. 2002 May 9;417(6885):182-7 - PubMed
- J Exp Med. 1988 Nov 1;168(5):1573-86 - PubMed
- J Immunol. 2013 May 1;190(9):4489-99 - PubMed
- Mediators Inflamm. 2015;2015:816460 - PubMed
- Blood. 1999 Aug 1;94(3):1012-20 - PubMed
- Eur J Immunol. 2011 Feb;41(2):366-79 - PubMed
- J Immunol. 2015 Jul 15;195(2):661-71 - PubMed
- J Pathol. 2005 May;206(1):17-27 - PubMed
- J Immunol. 2013 Dec 15;191(12):5914-24 - PubMed
- Nat Rev Immunol. 2020 Apr;20(4):254-267 - PubMed
- J Allergy Clin Immunol. 2018 Dec;142(6):1884-1893.e6 - PubMed
- Nat Med. 2020 Aug;26(8):1295-1306 - PubMed
- Arthritis Rheum. 2008 Mar;58(3):678-88 - PubMed
- J Clin Invest. 2017 Mar 1;127(3):954-969 - PubMed
- Allergy. 2021 Mar;76(3):775-788 - PubMed
- Arthritis Rheum. 2003 Apr;48(4):971-81 - PubMed
- Cell Rep. 2014 Oct 23;9(2):591-604 - PubMed
- Cell Death Differ. 2008 Jan;15(1):192-201 - PubMed
- Nat Immunol. 2019 Jul;20(7):928-942 - PubMed
- Nat Immunol. 2014 Oct;15(10):929-937 - PubMed
- Exp Cell Res. 2004 Jan 15;292(2):403-16 - PubMed
- J Biol Chem. 1997 Mar 14;272(11):6972-8 - PubMed
- Nat Rev Mol Cell Biol. 2001 Aug;2(8):627-33 - PubMed
- Chest. 2013 Jun;143(6):1750-1757 - PubMed
- Curr Opin Rheumatol. 2004 Jul;16(4):411-8 - PubMed
- J Clin Invest. 1998 Feb 15;101(4):890-8 - PubMed
- Front Pediatr. 2019 Jun 18;7:246 - PubMed
- Clin Exp Allergy. 2000 May;30(5):685-98 - PubMed
- J Cell Biol. 2001 Nov 12;155(4):649-59 - PubMed
- J Cell Physiol. 2019 Jul;234(7):10018-10031 - PubMed
- Am J Respir Crit Care Med. 2021 Apr 15;203(8):946-956 - PubMed
- Allergy. 2019 Jun;74(6):1090-1101 - PubMed
- J Biol Chem. 2015 May 22;290(21):13202-14 - PubMed
- Nat Rev Immunol. 2020 Feb;20(2):95-112 - PubMed
- Mol Med. 2010 Nov-Dec;16(11-12):552-7 - PubMed
- PLoS Pathog. 2017 Mar 23;13(3):e1006233 - PubMed
- Immunity. 2009 Aug 21;31(2):245-58 - PubMed
- Immunology. 1985 Dec;56(4):673-81 - PubMed
- J Immunol. 2005 May 15;174(10):6440-8 - PubMed
- Ann Rheum Dis. 2004 Jul;63(7):785-90 - PubMed
- Cell. 2019 Apr 18;177(3):541-555.e17 - PubMed
- Ann Rheum Dis. 2016 Dec;75(12):2184-2191 - PubMed
- Ann Rheum Dis. 2016 Dec;75(12):2192-2200 - PubMed
- J Immunol. 1989 Dec 1;143(11):3524-31 - PubMed
- Immunity. 2014 Jul 17;41(1):21-35 - PubMed
- Vasc Cell. 2013 Jun 01;5(1):11 - PubMed
- Mucosal Immunol. 2016 Jan;9(1):38-55 - PubMed
- Cell Death Differ. 2017 Jun;24(6):971-983 - PubMed
- Autoimmun Rev. 2021 Mar;20(3):102758 - PubMed
- Ann Rheum Dis. 2019 Dec;78(12):1642-1652 - PubMed
- Front Immunol. 2018 Mar 28;9:644 - PubMed
- Theranostics. 2015 Jan 01;5(2):150-72 - PubMed
- Arthritis Rheum. 2004 May;50(5):1457-67 - PubMed
- Ann Rheum Dis. 2016 Apr;75(4):763-71 - PubMed
- J Immunol. 2009 Nov 15;183(10):6469-77 - PubMed
- Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1970-8 - PubMed
- Semin Immunol. 2015 Dec;27(6):369-78 - PubMed
- Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737): - PubMed
- Nature. 2013 Apr 11;496(7444):238-42 - PubMed
- Ann Rheum Dis. 2011 Jun;70(6):1160-2 - PubMed
- Apoptosis. 2007 Feb;12(2):363-74 - PubMed
- Nat Commun. 2018 Nov 19;9(1):4863 - PubMed
- Arthritis Res Ther. 2015 Nov 13;17:324 - PubMed
- Am J Respir Cell Mol Biol. 2004 Jul;31(1):22-7 - PubMed
- Nat Immunol. 2021 Jan;22(1):10-18 - PubMed
- FASEB J. 2008 Aug;22(8):2629-38 - PubMed
- Immunity. 2017 Jul 18;47(1):66-79.e5 - PubMed
- Blood. 2014 May 15;123(20):e110-22 - PubMed
- Semin Immunopathol. 2011 Sep;33(5):419-40 - PubMed
- Transl Res. 2018 Jan;191:1-14 - PubMed
- Cell Death Dis. 2021 Apr 7;12(4):373 - PubMed
- Nat Commun. 2017 Nov 17;8(1):1595 - PubMed
- N Engl J Med. 2011 Dec 8;365(23):2205-19 - PubMed
- J Clin Invest. 2017 Feb 1;127(2):564-568 - PubMed
- Nat Chem Biol. 2017 Sep;13(9):951-955 - PubMed
- J Innate Immun. 2012;4(5-6):478-88 - PubMed
- Am J Respir Cell Mol Biol. 2016 Oct;55(4):467-475 - PubMed
- Nat Immunol. 2019 Dec;20(12):1631-1643 - PubMed
- Ann Rheum Dis. 2015 Mar;74(3):611-7 - PubMed
- Annu Rev Cell Dev Biol. 2017 Oct 6;33:127-144 - PubMed
- Nature. 1998 Apr 2;392(6675):505-9 - PubMed
- Exp Cell Res. 2020 Jan 1;386(1):111708 - PubMed
- J Cell Sci. 2005 Feb 1;118(Pt 3):539-53 - PubMed
- Nat Rev Immunol. 2011 Oct 25;11(11):750-61 - PubMed
- Immunity. 2017 Nov 21;47(5):913-927.e6 - PubMed
- Front Immunol. 2021 Apr 02;12:652771 - PubMed
- Cell Metab. 2019 Feb 5;29(2):443-456.e5 - PubMed
- Nat Rev Rheumatol. 2017 Sep;13(9):538-547 - PubMed
- Front Immunol. 2019 Jul 03;10:1462 - PubMed
- Allergy. 2015 Jan;70(1):80-9 - PubMed
- Arthritis Res Ther. 2007;9(6):224 - PubMed
- Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1429-31 - PubMed
- Autoimmunity. 2007 Jun;40(4):342-4 - PubMed
- Nat Rev Immunol. 2003 Jan;3(1):23-35 - PubMed
- Br J Rheumatol. 1997 Sep;36(9):935-40 - PubMed
- J Clin Invest. 2016 Apr 1;126(4):1173-80 - PubMed
- Arthritis Rheum. 1975 Nov-Dec;18(6):541-51 - PubMed
- J Biochem. 2000 Mar;127(3):411-7 - PubMed
- Nat Immunol. 2006 Nov;7(11):1209-16 - PubMed
- J Immunol. 2004 Apr 1;172(7):4410-7 - PubMed
- Int J Mol Sci. 2017 Apr 22;18(4): - PubMed
- J Cell Sci. 2018 Jun 5;131(11): - PubMed
- J Biol Chem. 2001 Jan 12;276(2):1071-7 - PubMed
- Cell Commun Signal. 2020 Nov 30;18(1):188 - PubMed
- Inflamm Res. 2020 Jan;69(1):139-151 - PubMed
- Nat Immunol. 2012 Nov;13(11):1118-28 - PubMed
- J Transl Med. 2017 Feb 15;15(1):36 - PubMed
- Cien Saude Colet. 2013 Jun;18(6):1827-34 - PubMed
- Nat Commun. 2019 Aug 2;10(1):3471 - PubMed
- Nature. 2016 Aug 4;536(7614):86-90 - PubMed
- Rheumatol Int. 1990;10(1):13-9 - PubMed
- Arch Orthop Trauma Surg. 1996;115(6):347-50 - PubMed
- Rheumatology (Oxford). 2014 Mar;53(3):415-24 - PubMed
- Trends Mol Med. 2010 Oct;16(10):458-68 - PubMed
- Front Immunol. 2020 Mar 31;11:553 - PubMed
- J Cell Biol. 2004 Dec 20;167(6):1161-70 - PubMed
- J Allergy Clin Immunol. 2019 Aug;144(2):426-441.e3 - PubMed
- Arthritis Res Ther. 2019 Jun 7;21(1):143 - PubMed
- Eur J Immunol. 2008 Dec;38(12):3257-64 - PubMed
- J Lipid Res. 2010 Aug;51(8):2105-20 - PubMed
- Immune Netw. 2018 Aug 13;18(4):e27 - PubMed
- Immunity. 2017 Feb 21;46(2):183-196 - PubMed
- Nat Immunol. 2005 Dec;6(12):1191-7 - PubMed
- Front Immunol. 2020 Dec 07;11:534501 - PubMed
- Nature. 2019 Aug;572(7771):670-675 - PubMed
- Chest. 2006 Jun;129(6):1673-82 - PubMed
- Sci Rep. 2019 Apr 10;9(1):5875 - PubMed
- J Allergy Clin Immunol. 2012 Jun;129(6):1621-7.e3 - PubMed
- Arthritis Rheum. 2002 May;46(5):1371-8 - PubMed
- Ann Rheum Dis. 2013 Dec;72(12):2024-31 - PubMed
- Arthritis Res Ther. 2019 Jul 8;21(1):169 - PubMed
- Am J Respir Crit Care Med. 2004 Feb 1;169(3):378-85 - PubMed
- J Biol Chem. 2006 Dec 15;281(50):38376-84 - PubMed
- Int J Mol Sci. 2020 Jul 21;21(14): - PubMed
- Sci Transl Med. 2019 May 8;11(491): - PubMed
- Arthritis Rheumatol. 2014 Mar;66(3):513-22 - PubMed
- Arthritis Rheumatol. 2015 Nov;67(11):2877-87 - PubMed
- Nat Rev Dis Primers. 2018 Feb 08;4:18001 - PubMed
- J Allergy Clin Immunol. 2017 Oct;140(4):1144-1146.e4 - PubMed
- J Immunol. 1991 Oct 1;147(7):2187-95 - PubMed
- Immunity. 2007 Dec;27(6):952-64 - PubMed
- Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L730-9 - PubMed
- Cell Metab. 2020 Jul 7;32(1):71-86.e5 - PubMed
- J Immunol. 1992 Apr 1;148(7):2207-16 - PubMed
- Arthritis Rheum. 2000 Sep;43(9):1951-9 - PubMed
- Cell Death Differ. 2004 Aug;11(8):943-5 - PubMed
- J Allergy Clin Immunol. 2019 May;143(5):1769-1782.e11 - PubMed
- Nat Rev Rheumatol. 2014 Jun;10(6):356-64 - PubMed
- Arthritis Rheum. 2003 Apr;48(4):1002-14 - PubMed
- Inflammation. 2015 Dec;38(6):2067-75 - PubMed
- Arthritis Res Ther. 2014;16(2):R90 - PubMed
- Matrix Biol. 2019 Jan;75-76:160-169 - PubMed
- FEBS Lett. 1993 Oct 18;332(3):221-5 - PubMed
- J Immunol. 2015 Apr 15;194(8):3664-74 - PubMed
- PLoS One. 2013 Jul 30;8(7):e70691 - PubMed
- Clin Exp Allergy. 2021 Jan 10;: - PubMed
- J Immunol. 2013 Apr 1;190(7):3579-89 - PubMed
- Rheumatology (Oxford). 2010 Apr;49(4):671-82 - PubMed
- J Clin Invest. 1992 Sep;90(3):772-9 - PubMed
- J Allergy Clin Immunol. 2021 Mar;147(3):921-932.e9 - PubMed
- Eur J Immunol. 2021 Apr;51(4):903-914 - PubMed
- J Immunol. 1999 Jun 1;162(11):6800-10 - PubMed
- Immunotargets Ther. 2020 Mar 09;9:43-56 - PubMed
- Front Immunol. 2018 Jan 05;8:1932 - PubMed
- J Pathol. 2015 Feb;235(3):515-26 - PubMed
- Front Immunol. 2015 Feb 24;6:79 - PubMed
- Lancet. 2017 Jun 10;389(10086):2328-2337 - PubMed
- Front Immunol. 2020 Mar 31;11:405 - PubMed
- Pharmacol Ther. 2021 Feb;218:107670 - PubMed
- Essays Biochem. 2003;39:105-17 - PubMed
- Immunity. 2014 Jul 17;41(1):14-20 - PubMed
- Cell Death Dis. 2017 Jun 8;8(6):e2860 - PubMed
- J Leukoc Biol. 2021 Jul;110(1):107-114 - PubMed
- Joint Bone Spine. 2013 Oct;80(5):449-53 - PubMed
- Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1421-8 - PubMed
- Rheum Dis Clin North Am. 2010 May;36(2):311-23 - PubMed
- Cell Death Differ. 2019 Sep;26(9):1646-1655 - PubMed
- Bull World Health Organ. 1972;46(6):845-52 - PubMed
- Arthritis Rheum. 1997 Jun;40(6):1096-105 - PubMed
- Am J Physiol Lung Cell Mol Physiol. 2015 Feb 15;308(4):L358-67 - PubMed
- Nat Commun. 2016 Sep 23;7:12859 - PubMed
- Front Med (Lausanne). 2020 May 21;7:191 - PubMed
- Stem Cells Transl Med. 2017 Mar;6(3):1018-1028 - PubMed
- Ann Rheum Dis. 2005 Jun;64(6):865-70 - PubMed
- J Clin Invest. 2009 Jan;119(1):20-32 - PubMed
- Ann Rheum Dis. 2011 Jun;70(6):1052-9 - PubMed
- Arthritis Rheum. 2011 Jan;63(1):53-62 - PubMed
- Rheumatology (Oxford). 2012 Mar;51(3):451-9 - PubMed
- Nature. 2009 Sep 10;461(7261):282-6 - PubMed
- Swiss Med Wkly. 2012 Feb 24;142:w13529 - PubMed
- J Pathol. 2013 Jan;229(2):250-63 - PubMed
- Front Immunol. 2018 Sep 03;9:1973 - PubMed
- Open Rheumatol J. 2012;6:209-19 - PubMed
- Wellcome Open Res. 2020 May 26;5:101 - PubMed
- Trends Biochem Sci. 2017 Sep;42(9):738-748 - PubMed
- Nature. 2007 Nov 15;450(7168):430-4 - PubMed
- Open Rheumatol J. 2011;5:100-6 - PubMed
- Nat Immunol. 2015 Sep;16(9):907-17 - PubMed
- Nat Rev Immunol. 2010 Dec;10(12):826-37 - PubMed
- Rheumatology (Oxford). 2013 Apr;52(4):590-8 - PubMed
- Cells. 2013 May 22;2(2):330-48 - PubMed
- Curr Opin Microbiol. 2015 Aug;26:32-40 - PubMed
- Lancet Respir Med. 2014 Aug;2(8):657-70 - PubMed
- Science. 2011 Apr 8;332(6026):243-7 - PubMed
- Nature. 2007 Nov 15;450(7168):435-9 - PubMed
- Front Immunol. 2018 Jun 28;9:1486 - PubMed
- Cell Death Differ. 2012 Apr;19(4):671-9 - PubMed
- Arthritis Rheum. 1991 Sep;34(9):1125-32 - PubMed
- Nat Rev Immunol. 2009 Aug;9(8):581-93 - PubMed
- Arthritis Rheum. 1982 May;25(5):488-501 - PubMed
- Nat Immunol. 2001 Jul;2(7):612-9 - PubMed
- Int J Mol Sci. 2017 Jul 17;18(7): - PubMed
- Blood. 2006 Jun 15;107(12):4930-7 - PubMed
- Wiley Interdiscip Rev Syst Biol Med. 2009 Jul-Aug;1(1):73-88 - PubMed
- Cell. 2003 Mar 7;112(5):645-57 - PubMed
- Front Immunol. 2014 Nov 10;5:570 - PubMed
- J Leukoc Biol. 2001 Nov;70(5):708-14 - PubMed
- Sci Rep. 2020 May 13;10(1):7907 - PubMed
- Microbiol Spectr. 2016 Jun;4(3): - PubMed
- Front Immunol. 2012 Jan 31;3:4 - PubMed
- Cell. 2005 Oct 21;123(2):321-34 - PubMed
- Blood. 2012 Oct 11;120(15):e60-72 - PubMed
- Nat Cell Biol. 2000 Dec;2(12):899-905 - PubMed
- Br J Cancer. 1972 Aug;26(4):239-57 - PubMed
- Am J Respir Cell Mol Biol. 2017 Jul;57(1):66-76 - PubMed
- Nat Rev Immunol. 2008 May;8(5):349-61 - PubMed
- Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11001-6 - PubMed
- Clin Exp Allergy. 2020 May;50(5):609-624 - PubMed
- Nat Immunol. 2003 Jan;4(1):87-91 - PubMed
- Int J Immunogenet. 2021 Jun;48(3):260-265 - PubMed
- J Exp Med. 2012 Mar 12;209(3):607-22 - PubMed
- Exp Ther Med. 2020 Sep;20(3):2352-2360 - PubMed
- J Clin Invest. 2012 Mar;122(3):787-95 - PubMed
- Sci Rep. 2017 Aug 2;7(1):7143 - PubMed
- Nat Immunol. 2019 May;20(5):571-580 - PubMed
- J Clin Invest. 2003 Aug;112(3):389-97 - PubMed
- Nature. 1997 Nov 27;390(6658):350-1 - PubMed
- Br J Rheumatol. 1992 Oct;31(10):653-61 - PubMed
- J Rheumatol. 1991 Sep;18(9):1282-4 - PubMed
- Nat Commun. 2014 Aug 06;5:4593 - PubMed
- Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51 - PubMed
- Adv Exp Med Biol. 2016;930:51-88 - PubMed
- PLoS One. 2009 Nov 17;4(11):e7865 - PubMed
- J Autoimmun. 2020 Jun;110:102392 - PubMed
- J Am Soc Nephrol. 2018 Mar;29(3):880-905 - PubMed
- Cell Res. 2020 Apr;30(4):300-314 - PubMed
- Ann Rheum Dis. 2020 Jun;79(6):685-699 - PubMed
- Nat Commun. 2014 Nov 13;5:5444 - PubMed
- J Allergy Clin Immunol. 2021 Mar;147(3):1087-1092.e3 - PubMed
- Clin Exp Allergy. 2013 Jan;43(1):29-35 - PubMed
- J Allergy Clin Immunol. 2020 Dec;146(6):1406-1418.e7 - PubMed
- J Cell Biochem. 2008 Dec 1;105(5):1211-8 - PubMed
- J Transl Med. 2020 Feb 5;18(1):58 - PubMed
- Sci Rep. 2018 Sep 6;8(1):13325 - PubMed
- Arthritis Rheum. 2007 Jul;56(7):2192-201 - PubMed
- Autoimmun Rev. 2005 Mar;4(3):130-6 - PubMed
- J Lipid Res. 2018 Nov;59(11):2037-2046 - PubMed
- Clin Exp Allergy. 2013 Feb;43(2):212-22 - PubMed
- PLoS One. 2011;6(9):e25683 - PubMed
- Mediators Inflamm. 2020 Aug 19;2020:7835284 - PubMed
- J Allergy Clin Immunol. 2021 Apr;147(4):1242-1260 - PubMed
- Autoimmun Rev. 2019 Dec;18(12):102398 - PubMed
- Nat Med. 2009 Jul;15(7):774-80 - PubMed
- Int J Cancer. 2009 Jun 1;124(11):2621-33 - PubMed
- Biochimie. 2020 Nov;178:69-80 - PubMed
- Biochem Soc Trans. 2019 Apr 30;47(2):509-516 - PubMed
- Nat Rev Mol Cell Biol. 2020 Jul;21(7):398-414 - PubMed
- Biomed J. 2021 Apr;44(2):172-182 - PubMed
- Am J Pathol. 1993 Mar;142(3):755-63 - PubMed
- Front Immunol. 2014 May 12;5:211 - PubMed
- Respir Med. 2012 Jan;106(1):9-14 - PubMed
- Immunol Lett. 2014 Nov;162(1 Pt A):200-6 - PubMed
- Front Immunol. 2011 Oct 10;2:52 - PubMed
Publication Types
Grant support